Works matching AU Kosiorek, Heidi E.

Results: 60
    1
    2

    Prevalent hepatitis B surface antigen among first-time blood donors in Gabon.

    Published in:
    PLoS ONE, 2018, v. 13, n. 4, p. 1, doi. 10.1371/journal.pone.0194285
    By:
    • Eko Mba, Jean Marie;
    • Bisseye, Cyrille;
    • Ntsame Ndong, Jophrette Mireille;
    • Mombo, Landry Erik;
    • Bengone, Calixte;
    • Mouelet Migolet, Guy;
    • M’batchi, Bertrand;
    • Kosiorek, Heidi E.;
    • Butterfield, Richard J.;
    • Roberts, Lewis R.;
    • Borad, Mitesh J.;
    • Nagalo, Bolni Marius
    Publication type:
    Article
    3
    4
    5

    The role of sexuality symptoms in myeloproliferative neoplasm symptom burden and quality of life: An analysis by the MPN QOL International Study Group.

    Published in:
    2016
    By:
    • Geyer, Holly L.;
    • Andreasson, Bjorn;
    • Kosiorek, Heidi E.;
    • Dueck, Amylou C.;
    • Scherber, Robyn M.;
    • Martin, Kari A.;
    • Butler, Kristina A.;
    • Harrison, Claire N.;
    • Radia, Deepti H.;
    • Cervantes, Francisco;
    • Kiladjian, Jean‐Jacques;
    • Reiter, Andreas;
    • Birgegard, Gunnar;
    • Passamonti, Francesco;
    • Senyak, Zhenya;
    • Vannucchi, Alessandro M.;
    • Paoli, Chiara;
    • Xiao, Zhijian;
    • Samuelsson, Jan;
    • Mesa, Ruben A.
    Publication type:
    journal article
    6
    7

    Quality of life independently predicts overall survival in myelofibrosis: Key insights from the COntrolled MyeloFibrosis Study with ORal Janus kinase inhibitor Treatment (COMFORT)‐I study.

    Published in:
    British Journal of Haematology, 2022, v. 198, n. 6, p. 1065, doi. 10.1111/bjh.18329
    By:
    • Kosiorek, Heidi E.;
    • Scherber, Robyn M.;
    • Geyer, Holly L.;
    • Verstovsek, Srdan;
    • Langlais, Blake T.;
    • Mazza, Gina L.;
    • Gotlib, Jason;
    • Gupta, Vikas;
    • Padrnos, Leslie J.;
    • Palmer, Jeanne M.;
    • Fleischman, Angela;
    • Mesa, Ruben A.;
    • Dueck, Amylou C.
    Publication type:
    Article
    8

    Personalized circulating tumor DNA analysis to detect residual disease after neoadjuvant therapy in breast cancer.

    Published in:
    Science Translational Medicine, 2019, v. 11, n. 504, p. 1, doi. 10.1126/scitranslmed.aax7392
    By:
    • McDonald, Bradon R.;
    • Contente-Cuomo, Tania;
    • Sammut, Stephen-John;
    • Odenheimer-Bergman, Ahuva;
    • Ernst, Brenda;
    • Perdigones, Nieves;
    • Chin, Suet-Feung;
    • Farooq, Maria;
    • Mejia, Rosa;
    • Cronin, Patricia A.;
    • Anderson, Karen S.;
    • Kosiorek, Heidi E.;
    • Northfelt, Donald W.;
    • McCullough, Ann E.;
    • Patel, Bhavika K.;
    • Weitzel, Jeffrey N.;
    • Slavin, Thomas P.;
    • Caldas, Carlos;
    • Pockaj, Barbara A.;
    • Murtaza, Muhammed
    Publication type:
    Article
    9

    A Novel Combination of the mTORC1 Inhibitor Everolimus and the Immunomodulatory Drug Lenalidomide Produces Durable Responses in Patients With Heavily Pretreated Relapsed Lymphoma.

    Published in:
    2018
    By:
    • Padrnos, Leslie;
    • Ernst, Brenda;
    • Dueck, Amylou C.;
    • Kosiorek, Heidi E.;
    • Ginos, Brenda F.;
    • Toro, Angela;
    • Johnston, Patrick B.;
    • Habermann, Thomas M.;
    • Leis, Jose F.;
    • Mikhael, Joseph R.;
    • Nowakowski, Grzegorz S.;
    • Colgan, Joseph;
    • Porrata, Luis;
    • Ansell, Stephen M.;
    • Witzig, Thomas E.;
    • Reeder, Craig
    Publication type:
    journal article
    10
    11
    12

    Evaluation of NUC-1031: a first-in-class ProTide in biliary tract cancer.

    Published in:
    2020
    By:
    • Arora, Mansi;
    • Bogenberger, James M.;
    • Abdelrahman, Amro;
    • Leiting, Jennifer L.;
    • Chen, Xianfeng;
    • Egan, Jan B.;
    • Kasimsetty, Aradhana;
    • Lenkiewicz, Elzbieta;
    • Malasi, Smriti;
    • Uson, Pedro Luiz Serrano;
    • Nagalo, Bolni Marius;
    • Zhou, Yumei;
    • Salomao, Marcela A.;
    • Kosiorek, Heidi E.;
    • Braggio, Esteban;
    • Barrett, Michael T.;
    • Truty, Mark J.;
    • Borad, Mitesh J.
    Publication type:
    journal article
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22

    Is There a Relationship Between TILs and Regression in Melanoma?

    Published in:
    Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2022, v. 29, n. 5, p. 2854, doi. 10.1245/s10434-021-11251-z
    By:
    • Morrison, Steven;
    • Han, Gang;
    • Elenwa, Faith;
    • Vetto, John T.;
    • Fowler, Graham;
    • Leong, Stanley P.;
    • Kashani-Sabet, Mohammed;
    • Pockaj, Barbara;
    • Kosiorek, Heidi E.;
    • Zager, Jonathan S.;
    • Messina, Jane L.;
    • Mozzillo, Nicola;
    • Schneebaum, Schlomo;
    • Han, Dale
    Publication type:
    Article
    23

    Same-Day Discharge After Mastectomy: Breast Cancer Surgery in the Era of ERAS®.

    Published in:
    Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2020, v. 27, n. 9, p. 3436, doi. 10.1245/s10434-020-08386-w
    By:
    • Jogerst, Kristen;
    • Thomas, Olivia;
    • Kosiorek, Heidi E.;
    • Gray, Richard;
    • Cronin, Patricia;
    • Casey III, William;
    • Rebecca, Alanna;
    • Craner, Ryan;
    • Young-Fadok, Tonia;
    • Pockaj, Barbara
    Publication type:
    Article
    24
    25
    26

    FGFR2-IIIb Expression by Immunohistochemistry Has High Specificity in Cholangiocarcinoma with FGFR2 Genomic Alterations.

    Published in:
    Digestive Diseases & Sciences, 2022, v. 67, n. 8, p. 3797, doi. 10.1007/s10620-021-07303-9
    By:
    • Uson Junior, Pedro Luiz Serrano;
    • DeLeon, Thomas T.;
    • Bogenberger, James M.;
    • Pai, Rish K.;
    • Kosiorek, Heidi E.;
    • Yin, Jun;
    • Ahn, Daniel H.;
    • Sonbol, Mohammad Bassam;
    • Bekaii-Saab, Tanios;
    • Mansfield, Aaron S.;
    • Buetow, Kenneth;
    • Gores, Gregory J.;
    • Smoot, Rory;
    • Vasmatzis, George;
    • Kipp, Benjamin R.;
    • Mahipal, Amit;
    • Baker, Alexander T.;
    • Babiker, Hani;
    • Barro, Oumar;
    • Dumbauld, Chelsae
    Publication type:
    Article
    27

    Unplanned implant removal in locally advanced breast cancer.

    Published in:
    Breast Journal, 2021, v. 27, n. 5, p. 466, doi. 10.1111/tbj.14224
    By:
    • Anderson, Justin D.;
    • Hammond, Jacob B.;
    • Kosiorek, Heidi E.;
    • Thorpe, Cameron S.;
    • Bhangoo, Ronik S.;
    • Pockaj, Barbara A.;
    • Gray, Richard J.;
    • Cronin, Patricia A.;
    • Rebecca, Alanna M.;
    • Casey, William J.;
    • Wong, William W.;
    • Keole, Sameer R.;
    • Vern‐Gross, Tamara Z.;
    • McGee, Lisa A.;
    • Halyard, Michele Y.;
    • DeWees, Todd A.;
    • Vargas, Carlos E.
    Publication type:
    Article
    28
    29
    30
    31
    32
    33
    34
    35
    36

    MUC1 Vaccines, Comprised of Glycosylated or Non-Glycosylated Peptides or Tumor-Derived MUC1, Can Circumvent Immunoediting to Control Tumor Growth in MUC1 Transgenic Mice.

    Published in:
    PLoS ONE, 2016, v. 11, n. 1, p. 1, doi. 10.1371/journal.pone.0145920
    By:
    • Lakshminarayanan, Vani;
    • Supekar, Nitin T.;
    • Wei, Jie;
    • McCurry, Dustin B.;
    • Dueck, Amylou C.;
    • Kosiorek, Heidi E.;
    • Trivedi, Priyanka P.;
    • Bradley, Judy M.;
    • Madsen, Cathy S.;
    • Pathangey, Latha B.;
    • Hoelzinger, Dominique B.;
    • Wolfert, Margreet A.;
    • Boons, Geert-Jan;
    • Cohen, Peter A.;
    • Gendler, Sandra J.
    Publication type:
    Article
    37
    38
    39
    40
    41

    Integrated analysis of next generation sequencing minimal residual disease (MRD) and PET scan in transplant eligible myeloma patients.

    Published in:
    Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00794-x
    By:
    • Fonseca, Rodrigo;
    • Arribas, Mariano;
    • Wiedmeier-Nutor, Julia E.;
    • Kusne, Yael N.;
    • González Vélez, Miguel;
    • Kosiorek, Heidi E.;
    • Butterfield, Richard J.;
    • Kirsch, Ilan R.;
    • Mikhael, Joseph R.;
    • Stewart, A. Keith;
    • Reeder, Craig;
    • Larsen, Jeremy;
    • Bergsagel, P. Leif;
    • Fonseca, Rafael
    Publication type:
    Article
    42

    Integrated analysis of next generation sequencing minimal residual disease (MRD) and PET scan in transplant eligible myeloma patients.

    Published in:
    Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00794-x
    By:
    • Fonseca, Rodrigo;
    • Arribas, Mariano;
    • Wiedmeier-Nutor, Julia E.;
    • Kusne, Yael N.;
    • González Vélez, Miguel;
    • Kosiorek, Heidi E.;
    • Butterfield, Richard J.;
    • Kirsch, Ilan R.;
    • Mikhael, Joseph R.;
    • Stewart, A. Keith;
    • Reeder, Craig;
    • Larsen, Jeremy;
    • Bergsagel, P. Leif;
    • Fonseca, Rafael
    Publication type:
    Article
    43
    44
    45

    Assessment of clinical outcomes with immune checkpoint inhibitor therapy in melanoma patients with CDKN2A and TP53 pathogenic mutations.

    Published in:
    PLoS ONE, 2020, v. 15, n. 3, p. 1, doi. 10.1371/journal.pone.0230306
    By:
    • DeLeon, Thomas T.;
    • Almquist, Daniel R.;
    • Kipp, Benjamin R.;
    • Langlais, Blake T.;
    • Mangold, Aaron;
    • Winters, Jennifer L.;
    • Kosiorek, Heidi E.;
    • Joseph, Richard W.;
    • Dronca, Roxana S.;
    • Block, Matthew S.;
    • McWilliams, Robert R.;
    • Kottschade, Lisa A.;
    • Rumilla, Kandelaria M.;
    • Voss, Jesse S.;
    • Seetharam, Mahesh;
    • Sekulic, Aleksandar;
    • Markovic, Svetomir N.;
    • Bryce, Alan H.
    Publication type:
    Article
    46
    47
    48
    49
    50